IL128095A - Formulation for the treatment and / or prevention of insanity - Google Patents
Formulation for the treatment and / or prevention of insanityInfo
- Publication number
- IL128095A IL128095A IL12809597A IL12809597A IL128095A IL 128095 A IL128095 A IL 128095A IL 12809597 A IL12809597 A IL 12809597A IL 12809597 A IL12809597 A IL 12809597A IL 128095 A IL128095 A IL 128095A
- Authority
- IL
- Israel
- Prior art keywords
- compound
- composition according
- dementia
- pharmaceutically acceptable
- use according
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9615628.6A GB9615628D0 (en) | 1996-07-25 | 1996-07-25 | Formulation |
PCT/EP1997/003872 WO1998004258A1 (en) | 1996-07-25 | 1997-07-14 | Formulation for the treatment and/or prophylaxis of dementia |
Publications (2)
Publication Number | Publication Date |
---|---|
IL128095A0 IL128095A0 (en) | 1999-11-30 |
IL128095A true IL128095A (en) | 2002-07-25 |
Family
ID=10797487
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL12809597A IL128095A (en) | 1996-07-25 | 1997-07-14 | Formulation for the treatment and / or prevention of insanity |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP0918521B1 (zh) |
JP (1) | JP2000515868A (zh) |
KR (1) | KR20000029523A (zh) |
CN (1) | CN1226163A (zh) |
AR (1) | AR007983A1 (zh) |
AT (1) | ATE224711T1 (zh) |
BR (1) | BR9710546A (zh) |
CA (1) | CA2261233A1 (zh) |
CO (1) | CO5031290A1 (zh) |
CZ (1) | CZ22799A3 (zh) |
DE (1) | DE69715878T2 (zh) |
DK (1) | DK0918521T3 (zh) |
ES (1) | ES2184121T3 (zh) |
GB (1) | GB9615628D0 (zh) |
HK (1) | HK1021314A1 (zh) |
IL (1) | IL128095A (zh) |
NO (1) | NO990283L (zh) |
NZ (1) | NZ333704A (zh) |
PL (1) | PL331283A1 (zh) |
PT (1) | PT918521E (zh) |
TR (1) | TR199900141T2 (zh) |
TW (1) | TW426514B (zh) |
WO (1) | WO1998004258A1 (zh) |
ZA (1) | ZA976592B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9815383D0 (en) * | 1998-07-15 | 1998-09-16 | Smithkline Beecham Plc | Novel method of treatment |
EP1332124A1 (en) * | 2000-09-27 | 2003-08-06 | Dsm N.V. | Process for the carbonylation of a conjugated diene |
GB0428170D0 (en) * | 2004-12-23 | 2005-01-26 | Biopartners Ltd | Mono and Combination Therapy |
CN109988144B (zh) | 2017-12-29 | 2024-07-05 | 广州再极医药科技有限公司 | 芳香乙烯或芳香乙基类衍生物、其制备方法、中间体、药物组合物及应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0392803T3 (da) * | 1989-04-13 | 2004-10-18 | Beecham Group Plc | Hidtil ukendte forbindelser |
MX9300875A (es) * | 1992-02-20 | 1993-08-31 | Smithkline Beecham Plc | Procedimiento para la preparacion de compuestos azabiciclicos. |
GB9409705D0 (en) * | 1994-05-14 | 1994-07-06 | Smithkline Beecham Plc | Novel compounds |
DE19501022C1 (de) * | 1995-01-14 | 1996-06-05 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System zur Verabreichung von (s)-3-Methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazol oder einem seiner pharmazeutisch akzeptablen Salze und Verfahren zu seiner Herstellung |
-
1996
- 1996-07-25 GB GBGB9615628.6A patent/GB9615628D0/en active Pending
-
1997
- 1997-07-14 CN CN97196687A patent/CN1226163A/zh active Pending
- 1997-07-14 PT PT97934492T patent/PT918521E/pt unknown
- 1997-07-14 JP JP10508451A patent/JP2000515868A/ja active Pending
- 1997-07-14 WO PCT/EP1997/003872 patent/WO1998004258A1/en not_active Application Discontinuation
- 1997-07-14 CA CA002261233A patent/CA2261233A1/en not_active Abandoned
- 1997-07-14 CZ CZ99227A patent/CZ22799A3/cs unknown
- 1997-07-14 TR TR1999/00141T patent/TR199900141T2/xx unknown
- 1997-07-14 KR KR1019997000576A patent/KR20000029523A/ko not_active Application Discontinuation
- 1997-07-14 NZ NZ333704A patent/NZ333704A/en unknown
- 1997-07-14 ES ES97934492T patent/ES2184121T3/es not_active Expired - Lifetime
- 1997-07-14 EP EP97934492A patent/EP0918521B1/en not_active Expired - Lifetime
- 1997-07-14 BR BR9710546A patent/BR9710546A/pt unknown
- 1997-07-14 DK DK97934492T patent/DK0918521T3/da active
- 1997-07-14 DE DE69715878T patent/DE69715878T2/de not_active Expired - Fee Related
- 1997-07-14 IL IL12809597A patent/IL128095A/en not_active IP Right Cessation
- 1997-07-14 PL PL97331283A patent/PL331283A1/xx unknown
- 1997-07-14 AT AT97934492T patent/ATE224711T1/de not_active IP Right Cessation
- 1997-07-23 AR ARP970103327A patent/AR007983A1/es unknown
- 1997-07-24 TW TW086110515A patent/TW426514B/zh not_active IP Right Cessation
- 1997-07-24 ZA ZA976592A patent/ZA976592B/xx unknown
- 1997-07-25 CO CO97042583A patent/CO5031290A1/es unknown
-
1999
- 1999-01-22 NO NO990283A patent/NO990283L/no unknown
- 1999-12-01 HK HK99105593A patent/HK1021314A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR20000029523A (ko) | 2000-05-25 |
DE69715878D1 (de) | 2002-10-31 |
GB9615628D0 (en) | 1996-09-04 |
ES2184121T3 (es) | 2003-04-01 |
PL331283A1 (en) | 1999-07-05 |
JP2000515868A (ja) | 2000-11-28 |
CZ22799A3 (cs) | 1999-06-16 |
EP0918521B1 (en) | 2002-09-25 |
DK0918521T3 (da) | 2003-02-03 |
NZ333704A (en) | 2000-06-23 |
NO990283D0 (no) | 1999-01-22 |
IL128095A0 (en) | 1999-11-30 |
TR199900141T2 (xx) | 1999-03-22 |
CO5031290A1 (es) | 2001-04-27 |
NO990283L (no) | 1999-03-19 |
AR007983A1 (es) | 1999-11-24 |
AU3768497A (en) | 1998-02-20 |
ZA976592B (en) | 1999-03-04 |
HK1021314A1 (en) | 2000-06-09 |
DE69715878T2 (de) | 2003-05-22 |
ATE224711T1 (de) | 2002-10-15 |
CA2261233A1 (en) | 1998-02-05 |
CN1226163A (zh) | 1999-08-18 |
BR9710546A (pt) | 1999-08-17 |
TW426514B (en) | 2001-03-21 |
AU721101B2 (en) | 2000-06-22 |
EP0918521A1 (en) | 1999-06-02 |
WO1998004258A1 (en) | 1998-02-05 |
PT918521E (pt) | 2003-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3786684B2 (ja) | オキシブチニンの経皮投与 | |
US5747065A (en) | Monoglyceride/lactate ester permeation enhancer for oxybutynin | |
US4910205A (en) | Transdermal delivery of loratadine | |
US5900250A (en) | Monoglyceride/lactate ester permeation enhancer for oxybutnin | |
JPH11506462A (ja) | ロピニロールを含有してなる経皮製剤 | |
AU720504B2 (en) | Transdermal compositions containing levosimendan | |
US20020127271A1 (en) | Formulation for the treatment and/or prophylaxis of dementia | |
KR100437672B1 (ko) | 리스페리돈의방출조절형경피투여용제제 | |
EP0918521B1 (en) | Formulation for the treatment and/or prophylaxis of dementia | |
WO1997006788A1 (en) | Transdermal administration of vorozole | |
AU721101C (en) | Formulation for the treatment and/or prophylaxis of dementia | |
JPH09509676A (ja) | ツメを使用する系統的な薬品配送システム | |
EP1216036B1 (en) | Transdermal administration of n-(2,5-disubstituted phenyl)-n'-(3-substituted phenyl)-n'-methyl guanidines | |
JP2002521324A (ja) | フェノルドパムの経皮投与のための配合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
RH1 | Patent not in force |